论文已发表
提 交 论 文
注册即可获取Ebpay生命的最新动态
注 册
IF 收录期刊
用于妇科癌症治疗的聚合物纳米粒子研究进展
Authors Lin X , Li Z, Huang Y, Li Y , Li Y, Zhang L , Wu M
Received 8 March 2025
Accepted for publication 12 May 2025
Published 26 May 2025 Volume 2025:20 Pages 6721—6742
DOI http://doi.org/10.2147/IJN.S527023
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Professor Dong Wang
Xiaorui Lin,1,2 Zihan Li,1,2 Yibao Huang,1,2 Yinuo Li,1,2 Yuting Li,1,2 Ling Zhang,1,2 Mingfu Wu1,2
1National Clinical Research Center for Obstetrical and Gynecological Diseases, Department of Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, People’s Republic of China; 2Key Laboratory of Cancer Invasion and Metastasis, Ministry of Education, Wuhan 430030, People’s Republic of China
Correspondence: Mingfu Wu, Email mingfuwutj@163.com
Abstract: Gynecological cancers represent one of the leading causes of death in women and pose a critical global health challenge. While surgery and chemotherapy remain the first-line therapies for gynecological cancers, the persistently high morbidity and mortality rates have driven the urgent exploration of novel theranostic strategies. In recent years, polymer nanoparticles (PNPs) have gained increasing attention in the diagnosis and treatment of cancer due to their superior targeting ability and delivery efficiency. This review provides an overview of PNPs and their role in tumor diagnosis and treatment, with a strategic focus on their utility in gynecological cancers. It covers drug delivery, imaging, combination therapy, and theranostic integration in gynecological cancers, and summarizes the composition, principles and characteristics of diverse polymers and their cargoes. Furthermore, this work highlights innovative applications of PNPs in gynecological cancers management, spanning chemotherapy, immunotherapy, PARPi therapy, phototherapy and other therapies. Despite promising preclinical advancements in PNPs, formidable challenges persist in their clinical translation. This review serves as a comprehensive resource for researchers and clinicians aiming to optimize gynecological cancers theranostics as well as accelerate the development and clinical translation of PNPs.
Keywords: polymer nanoparticles, gynecological cancer, theranostics, nanoparticles, ovarian cancer, cervical cancer, endometrial cancer, nanomedicine